Primary hepatic malignant fibrous histiocytoma: Clinicopathologic characteristics and prognostic value of Ezrin expression

American Journal of Surgical Pathology

Volumn 32, Issue 8, 2008, Pages 1144-1158

  Li, Yun Ru ^a   Akbari, Elaheh ^a   Tretiakova, Maria S ^b   Hart, John ^b   Akbari, Majid ^c   Urbanski, Stefan J ^a   Gao, Zu Hua ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b LIONS GATE HOSPITAL   (Canada)

^c UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

Clinicopathology; Electron microscopy; Ezrin; Immunohistochemistry; Liver; Malignant fibrous histiocytoma

Indexed keywords

EZRIN; CYTOSKELETON PROTEIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOREACTIVITY; MALE; MALIGNANT FIBROUS HISTIOCYTOMA; PROTEIN EXPRESSION; ULTRASOUND; CHEMISTRY; CHROMOSOME ANALYSIS; DIFFERENTIAL DIAGNOSIS; GENE EXPRESSION REGULATION; GENETICS; IMMUNOHISTOCHEMISTRY; LIVER; LIVER RESECTION; LIVER TUMOR; MIDDLE AGED; MORTALITY; PATHOLOGY; REVIEW; SURVIVAL; TRANSMISSION ELECTRON MICROSCOPY; TREATMENT OUTCOME;

ADULT; AGED; CYTOGENETIC ANALYSIS; CYTOSKELETAL PROTEINS; DIAGNOSIS, DIFFERENTIAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATECTOMY; HISTIOCYTOMA, MALIGNANT FIBROUS; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER; LIVER NEOPLASMS; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; MIDDLE AGED; NEOPLASM STAGING; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 49249085073     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3181659791     Document Type: Article

References (57)

1. Akifuji Y, Honjo I, Katayama S, et al. Malignant fibrous histiocytoma. Intern Med. 1992;31:284-288.
2. Alberti-Flor JJ, O'Hara MF. Malignant fibrous histiocytoma of the liver. Gastroenterology. 1985;89:890-893.
3. Anagnostopoulos G, Sakorafas GH, Grigoriadis K, et al. Malignant fibrous histiocytoma of the liver: a case report and review of the literature. Mount Sinai J Med. 2005;72:50-52.
4. Arends JW, Willebrand D. Primary malignant fibrous histiocytoma of the liver: a case report with immunohistochemical observation. Histopathology. 1987;11:427-431.
5. Bretscher A, Edwards K, Fehon RG. ERM proteins and merlin: integrators at the cell cortex. Nat Rev Mol Biol. 2002;3:586-599.
6. Bruneton JN, Drouilard J, Rogopoulos A, et al. Extraretro-peritoneal abdominal malignant fibrous histiocytoma. Gastrointest Radiol. 1988;13:299-305.
7. Chang WWL, Agha FP, Morgan WS. Primary sarcoma of the liver in the adult. Cancer. 1983;51:1510-1517.
8. Coindre JM, Terrier P, Guillou L, et al. Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas: a study of 1240 patients from the French Federation of Cancer Centers Sarcoma Group. Cancer. 2001;91:1914-1926.
9. Conran RM, Stocker JT. Malignant fibrous histiocytoma of the liver: a case report. Am J Gastroenterol. 1985;80:813-815.
10. Curto M, McClatchey AI. Ezrin - a metastatic detERMinant? Cancer Cell. 2004;5:113-114.
11. Dai J, Shi M, Li G. Computed tomographic features of malignant fibrous histiocytoma. Clin J Oncol. 1996;18:140-142.
12. Ding GH, Wu MC, Yang JH, et al. Primary hepatic malignant fibrous histiocytoma mimicking cystadenocarcinoma: a case report. Hepatobiliary Pancreat Dis Int. 2006;5:620-623.
13. Du Boulay CEH. Demonstration of alpha-1-antitrypsin and alpha-1-antichymotrypsin in fibrous histiocytomas using the immunoper-oxidase technique. Am J Surg Pathol. 1982;6:559-564.
14. Erlandson RA, Antonescu CR. The rise and fall of malignant fibrous histiocytoma. Ultrastruct Pathol. 2004;28:283-289.
15. Ferozzi F, Bova D. Hepatic malignant fibrous histiocytoma: CT findings. Clin Radiol. 1998;53:699-701.
16. Fletcher CD. Pleomorphic malignant fibrous histiocytoma: fact or fiction? A critical reappraisal based on 159 tumors diagnosed as pleomorphic sarcoma. Am J Surg Pathol. 1992;16:213-228.
17. Fletcher CDM, Van den Berg E, Molenaar WM. Pleomorphic malignant fibrous histiocytoma/undifferentiated high grade pleo-morphic sarcoma. In: Fletcher CDM, Unni KK, Mertens F, eds. Pathology and Genetics: Tumors of Soft Tissue and Bone. World Health Organization Classification of Tumors. Lyon: IARC Press; 2002:121.
18. Fujita S, Lauwers GY. Primary hepatic malignant fibrous histiocy-toma: report of a case and review of the literature. Pathol Int. 1998;48:225-229.
19. Fukuyama M, Koike M. Malignant fibrous histiocytoma arising in the liver. Arch Pathol Lab Med. 1986;110:203-206.
20. Furuse J, Nagase M, Ishii H, et al. Contrast enhancement patterns of hepatic tumors during the vascular phase using coded harmonic imaging and Levovist to differentiate hepatocellular carcinoma from other focal lesions. Br J Radiol. 2003;76:385-392.
21. Goldman SM, Hartman DS, Weiss SW. The varied radiographic manifestations of retroperitoneal malignant fibrous histiocytoma revealed through 27 cases. J Urol. 1986;135:33-38.
22. Greene FL, Page DL, Flemming ID, et al. AJCC Cancer Staging Manual. 6th ed. New York: Springer-Verlag; 2002.
23. Hamasaki K, Mimura H, Sato S, et al. Malignant fibrous histiocytoma of the liver - a case report. Gastroenterol Japan. 1991;26:666-673.
24. Honda H, Nakamura Y, Katziwara T, et al. Malignant fibrous histiocytoma of the liver. Comput Med Imaging Graph. 1988;12: 131-134.
25. Isaacson P, Jones DB, Millward-Sadler GH, et al. Alpha-1-antitrypsin in human macrophages. J Clin Pathol. 1981;24: 982-990.
26. Katsuda S, Kawahara E, Matsui Y, et al. Malignant fibrous histiocytoma of the liver: a case report and review of the literature. Am J Gastroenterol. 1988;83:1278-1282.
27. Keating S, Taylor GP. Undifferentiated (embryonal) sarcoma of the liver: ultrastructural and immunohistochemical similarities with malignant fibrous histiocytoma. Human Pathol. 1985;16:693-699.
28. Khanna C, Wan X, Bose S, et al. The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis. Nat Med. 2004;10: 182-186.
29. Kim MS, Cho WH, Song WS, et al. Prognostic significance of ezrin expression in pleomorphic malignant fibrous histiocytoma. Anticancer Res. 2007;27:1171-1178.
30. Krandorf MJ. Malignant soft-tissue tumors in a large referral population: distribution of diagnoses by age, sex, and location. Am J Roentgenol. 1995;164:129-134.
31. Lack EE, Schloo BL, Azumi N, et al. Undifferentiated (embryonal) sarcoma of the liver. Am J Surg Pathol. 1991;15:1-16.
32. Lao X-M, Chen D-Y, Zhang Y-Q, et al. Primary carcinosarcoma of the liver: clinicopathologic features of 5 cases and a review of the literature. Am J Surg Pathol. 2007;31:817-826.
33. Lattes R. Malignant fibrous histiocytoma. A review article. Am J Surg Pathol. 1982;6:761-771.
34. Maeda T, Adachi E, Kajiyama K, et al. Spindle cell hepatocellular carcinoma: a clinicopathologic and immunohistochemical analysis of 15 cases. Cancer. 1996;77:51-57.
35. Mairal A, Terrier P, Chibon F, et al. Loss of chromosome 13 is the most frequent genomic imbalance in malignant fibrous histiocytomas. A comparative genomic hybridization analysis of a series of 30 cases. Cancer Genet Cytogenet. 1999;111:134-138.
36. Mandahl N, Heim S, Willén H, et al. Characteristic karyotypic anomalies identify subtypes of malignant fibrous histiocytoma. Genes Chromosomes Cancer. 1989;1:9-14.
37. McGrady BJ, Mirakhur MM. Recurrent malignant fibrous histio-cytoma of the liver. Histopathology. 1992;21:290-292.
38. O'Brien JE, Stout AP. Malignant fibrous xanthomas. Cancer. 1964;17:1445-1458.
39. Ohtomo K, Araki T, Itai Y, et al. MR imaging of malignant mesenchymal tumors of the liver. Gastrointest Radiol. 1992;17: 58-62.
40. Palmer PE, Wolfe HJ. Alpha-1-antitrypsin deposition in primary hepatic carcinomas. Arch Pathol Lab Med. 1976;100:232-237.
41. Pinson CW, Lopez RR, Ivancev K, et al. Resection of primary hepatic fibrous histiocytoma, fibrosarcoma, and leiomyosarcoma. South Med J. 1994;87:384-391.
42. Reed JG, Goodman P, Soloway RD. Primary malignant fibrous histiocytoma of the liver: MRI findings. Magn Reson Imaging. 1993;11:139-143.
43. Ros PR, Viamonte M, Rywlin AM. Review, malignant fibrous histiocytoma: mesenchymal tumor of ubiquitous origin. AJR. 1984;142:753-759.
44. Shimada M, Takenaka K, Rikimaru T, et al. Characteristics of sarcomatous cholangiocarcinoma of the liver. Hepatogastroenterology. 2000;47:956-961.
45. Walter TA, Weh HJ, Schlag PM, et al. Cytogenetic studies in malignant fibrous histiocytoma. Cancer Genet Cytogenet. 1997;94: 131-134.
46. Waxman M, Falgenburg D, Waxman JS, et al. Malignant fibrous histiocytoma of the colon associated with diverticulitis. Dis Colon Rectum. 1983;26:339-343.
47. Weinberg AG, Finegold MJ. Primary hepatic tumors of childhood. Hum Pathol. 1983;14:512-537.
48. Weiss SW. Malignant fibrous histiocytoma: a reaffirmation. Am J Surg Pathol. 1982;6:773.
49. Weiss SW, Enzinger FM. Malignant fibrous histiocytoma: an analysis of 200 cases. Cancer. 1978;41:2250-2266.
50. Weiss SW, Goldblum JR. Malignant fibrous histiocytoma. In: Weiss SW, Goldblum JR, eds. Enzinger and Weiss's Soft Tissue Tumors. 4th ed. Philadelphia, PA: Mosby-Harcourt; 2001:535-569.
51. Weng W, Åhlén J, Åström K, et al. Prognostic impact of immuno-histochemical expression of Ezrin in highly malignant soft tissue sarcomas. Clin Cancer Res. 2005;11:6198-6204.
52. Wunderbaldinger P, Schima W, Harisinghani M, et al. Primary malignant fibrous histiocytoma of the liver: CT and MR findings. Am J Roentgenol. 1998;171:900-901.
53. Ye M-F, Zheng S, Xu J-H, et al. Primary hepatic malignant fibrous histiocytoma: a case report and review of the literature. Histol Histopathol. 2007;22:1337-1342.
54. Yu JS, Kim CS, Kim KW, et al. Primary malignant fibrous histiocytoma of the liver: imaging features of five surgically confirmed cases. Abdom Imaging. 1999;24:386-391.
55. Yu Y, Khan J, Khanna C, et al. Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators. Nat Med. 2004;10:175-181.
56. Zamir D, Jarchowsky J, Singer C, et al. Inflammatory pseudotumor of the liver-a rare entity and a diagnostic challenge. Am J Gastroenterol. 1998;93:1538-1540.
57. Zornig C, Kremer B, Henne-Breuns D, et al. Primary sarcoma of the liver in the adult. Report of five surgically treated patients. Hepatogastroenterology. 1992;39:319-321.